Skip to content

CHINA HEALTH INDUSTRIES HOLDINGS, INC.: 10-Q filed 2022-02-14

What CHINA HEALTH INDUSTRIES HOLDINGS, INC. reported in its quarterly report filed 2022-02-14 (fiscal Q2 2022): 38 published measures, 107 facts as tagged in accession 0001213900-22-007230.

This filing

Form
10-Q (quarterly report)
Filed
2022-02-14
Fiscal period
fiscal Q2 2022
Accession
0001213900-22-007230 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA HEALTH INDUSTRIES HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-12-3154,010,934USD
At 2021-06-3053,888,137USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-12-3144,771,135USD
At 2021-09-3044,846,096USD
At 2021-06-3044,774,641USD
At 2020-12-3144,500,902USD
At 2020-09-3041,947,498USD
At 2020-06-3039,667,986USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-12-3147,066,157USD
At 2021-06-3044,346,744USD
At 2020-12-3140,666,095USD
At 2020-06-3036,072,474USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-573,524USD92
2021-07-01 to 2021-12-31-594,911USD184
2020-10-01 to 2020-12-31816,043USD92
2020-07-01 to 2020-12-311,455,735USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-07-01 to 2021-12-312,799,172USD184
2020-07-01 to 2020-12-312,347,484USD184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-07-01 to 2020-12-318,389USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2021-10-01 to 2021-12-312USD92
2021-07-01 to 2021-12-31268USD184
2020-10-01 to 2020-12-313,089,716USD92
2020-07-01 to 2020-12-315,281,798USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-07-01 to 2020-12-31-11,366USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-12-3141,455,718USD
At 2021-06-3042,050,629USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-107,057USD92
2020-10-01 to 2020-12-31344,742USD92
2020-07-01 to 2020-12-31618,935USD184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-12-313,495,601USD
At 2021-06-303,629,905USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-272,607USD92
2021-07-01 to 2021-12-31-709,108USD184
2020-10-01 to 2020-12-311,126,156USD92
2020-07-01 to 2020-12-312,008,254USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-12-3148,206,980USD
At 2021-06-3047,730,873USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-12-319,239,799USD
At 2021-06-309,113,496USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2021-12-311,737,077USD
At 2021-06-301,963,516USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-12-3149,175USD
At 2021-06-302,346,867USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-10-01 to 2021-12-31272,598USD92
2021-07-01 to 2021-12-31707,621USD184
2020-10-01 to 2020-12-31669,227USD92
2020-07-01 to 2020-12-311,027,431USD184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-12-31816,596USD
At 2021-06-30761,639USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-9USD92
2021-07-01 to 2021-12-31-1,487USD184
2020-10-01 to 2020-12-311,795,383USD92
2020-07-01 to 2020-12-313,035,685USD184

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2021-10-01 to 2021-12-3192,586USD92
2021-07-01 to 2021-12-31347,659USD184
2020-10-01 to 2020-12-31516,959USD92
2020-07-01 to 2020-12-31717,291USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-12-3165,539,737shares
At 2021-06-3065,539,737shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-12-31521,987USD
At 2021-06-30521,987USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2021-12-312,748,197USD
At 2021-06-302,156,792USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2021-12-3144,771,135USD
At 2021-06-3044,774,641USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2021-12-313,901,648USD
At 2021-06-303,671,106USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2021-12-311,737,077USD
At 2021-06-301,963,516USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-680,581USD92
2021-07-01 to 2021-12-31-594,911USD184
2020-10-01 to 2020-12-311,160,785USD92
2020-07-01 to 2020-12-312,074,670USD184

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-573,524USD92
2021-07-01 to 2021-12-31-594,911USD184
2020-10-01 to 2020-12-31816,043USD92
2020-07-01 to 2020-12-311,455,735USD184

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-74,961USD92
2021-07-01 to 2021-12-31-3,506USD184
2020-10-01 to 2020-12-312,553,404USD92
2020-07-01 to 2020-12-314,832,916USD184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2021-07-01 to 2021-12-31109,956USD184
2020-07-01 to 2020-12-31209,731USD184

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-10-01 to 2021-12-31180,012USD92
2021-07-01 to 2021-12-31359,962USD184
2020-10-01 to 2020-12-31152,268USD92
2020-07-01 to 2020-12-31310,140USD184

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2021-07-01 to 2021-12-31250,006USD184
2020-07-01 to 2020-12-31237,365USD184

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-448,420USD92
2021-07-01 to 2021-12-3132,882USD184
2020-10-01 to 2020-12-31562USD92
2020-07-01 to 2020-12-31504USD184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-407,974USD92
2021-07-01 to 2021-12-31114,197USD184
2020-10-01 to 2020-12-3134,629USD92
2020-07-01 to 2020-12-3166,416USD184

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-107,057USD92
2020-10-01 to 2020-12-31344,742USD92
2020-07-01 to 2020-12-31618,935USD184

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2021-10-01 to 2021-12-31-107,057USD92
2020-10-01 to 2020-12-31344,742USD92
2020-07-01 to 2020-12-31618,935USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-12-31-2,250,149USD184
2020-07-01 to 2020-12-31529,591USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-12-3143,226USD184
2020-07-01 to 2020-12-31103,931USD184

Inspect the source

Entity
CHINA HEALTH INDUSTRIES HOLDINGS, INC. / CIK 0001309057
Captured
SEC response SHA-256
93829603b3c881951d34b2b4bb637d2441d1808eaea70ed12e10811c21d923de

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001309057.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))